Outcome of etoposide and mitoxantrone for relapsed or refractory acute myeloid leukemia (RR-AML) in the modern era.

被引：0
|
作者：
Bowman, Zelia Ramone Karema
Caddell, Ryan James
Kanate, Abraham Sebastian
Shillingburg, Alex
Shah, Nilay Arvind
Craig, Michael
Cumpston, Aaron
机构：
[1] West Virginia Univ, Robert C Byrd Hlth Sci Ctr, Morgantown, WV USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] West Virginia Univ, Morgantown, WV USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18515
引用
收藏
页数：4
相关论文
共 50 条
  • [21] APhase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia
    Advani, Anjali S.
    Cooper, Brenda
    Visconte, Valeria
    Elson, Paul
    Chan, Ricky
    Carew, Jennifer
    Wei, Wei
    Mukherjee, Sudipto
    Gerds, Aaron
    Carraway, Hetty
    Nazha, Aziz
    Hamilton, Betty
    Sobecks, Ronald
    Caimi, Paolo
    Tomlinson, Benjamin
    Malek, Ehsan
    Little, Jane
    Miron, Alexander
    Pink, John
    Maciejewski, Jaroslaw
    Unger, Allison
    Kalaycio, Matt
    de Lima, Marcos
    Sekeres, Mikkael A.
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4231 - 4237
  • [22] A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results
    Advani, Anjali S.
    Cooper, Brenda W.
    Visconte, Valeria
    Elson, Paul
    Chan, E. Ricky
    Carew, Jennifer
    Mukherjee, Sudipto
    Gerds, Aaron T.
    Carraway, Hetty E.
    Nazha, Aziz
    Hamilton, Betty K.
    Sobecks, Ronald
    Caimi, Paolo
    Tomlinson, Benjamin
    Malek, Ehsan
    Little, Jane A.
    Fensterl, Jaime
    Unger, Allison
    Zimmerman, Cassie
    Goebel, Christopher
    Hoxha, Nita
    Siebenaller, Caitlin
    Thomas, Jenna
    Rush, Mary Lynn
    Bogati, Samjhana
    Parsons, Eric
    Diligente, Rachael
    Kane, Donna
    Nielsen, Alek
    Hirsch, Cassandra M.
    Edelheit, Simone
    Miron, Alexander
    Pink, John
    Maciejewski, Jaroslaw P.
    Kalaycio, Matt
    De Lima, Marcos
    Sekeres, Mikkael A.
    BLOOD, 2017, 130
  • [23] Phase I Study of the Combination of Azacitidine (AZA) with MEC (Mitoxantrone, Etoposide and Cytarabine) Salvage Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia (AML): Early Results
    Klisovic, Rebecca B.
    Wang, Hongyan
    Walker, Alison
    Walsh, Katherine
    Vasu, Sumithira
    Garzon, Ramiro
    Devine, Steven M.
    Wang, Jiang
    Garr, Celia
    Norris, Adam
    Byrd, John C.
    Grever, Michael R.
    Blum, William
    Chan, Kenneth K.
    Marcucci, Guido
    BLOOD, 2012, 120 (21)
  • [24] Cyclosporine Modulation of Multidrug Resistance in Combination with Pravastatin, Mitoxantrone, and Etoposide for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study
    Chen, Tara L.
    Estey, Elihu H.
    Othus, Megan
    Gardner, Kelda M.
    Markle, Lauren
    Walter, Roland B.
    BLOOD, 2012, 120 (21)
  • [25] MITOXANTRONE AND HIGH-DOSE ETOPOSIDE FOR PATIENTS WITH RELAPSED OR REFRACTORY ACUTE-LEUKEMIA
    OBRIEN, S
    KANTARJIAN, H
    ESTEY, E
    KOLLER, C
    BERAN, M
    MCCREDIE, K
    KEATING, M
    CANCER, 1991, 68 (04) : 691 - 694
  • [26] MITOXANTRONE IN RELAPSED OR REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA
    VREDENBURGH, JJ
    MCINTYRE, OR
    CORNWELL, GG
    BALI, ED
    CORNELL, CJ
    MILLS, LE
    ODONNELL, JF
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (03): : 187 - 189
  • [27] MITOXANTRONE FOR REFRACTORY AND RELAPSED ACUTE-LEUKEMIA
    BEZWODA, WR
    BERNASCONI, C
    HUTCHINSON, RM
    WINFIELD, DA
    DEBOCK, R
    MANDELLI, F
    CANCER, 1990, 66 (03) : 418 - 422
  • [28] MITOXANTRONE IN RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    VREDENBURG, JJ
    MCINTYRE, OR
    CORNWELL, GG
    BALL, ED
    CORNELL, CJ
    LEUKEMIA, 1987, 1 (03) : 278 - 278
  • [29] MITOXANTRONE IN RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    PRENTICE, HG
    ROBBINS, G
    MA, DDF
    HO, AD
    SEMINARS IN ONCOLOGY, 1984, 11 (03) : 32 - 35
  • [30] A phase I/II study of induction therapy with topotecan, mitoxantrone and etoposide in relapsed/refractory acute myeloid leukemia (AML), myeloid blast crisis and high risk myelodysplastic syndromes (MDS).
    Nand, S
    Godwin, J
    White, C
    Beltran, O
    Stiff, P
    BLOOD, 2000, 96 (11) : 214B - 214B
12345